289 related articles for article (PubMed ID: 29121499)
1. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
[TBL] [Abstract][Full Text] [Related]
2. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
Berbée JF; Boon MR; Khedoe PP; Bartelt A; Schlein C; Worthmann A; Kooijman S; Hoeke G; Mol IM; John C; Jung C; Vazirpanah N; Brouwers LP; Gordts PL; Esko JD; Hiemstra PS; Havekes LM; Scheja L; Heeren J; Rensen PC
Nat Commun; 2015 Mar; 6():6356. PubMed ID: 25754609
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
Zhou E; Li Z; Nakashima H; Choukoud A; Kooijman S; Berbée JFP; Rensen PCN; Wang Y
Pharmacol Res; 2021 May; 167():105524. PubMed ID: 33667684
[TBL] [Abstract][Full Text] [Related]
4. Mirabegron-induced brown fat activation does not exacerbate atherosclerosis in mice with a functional hepatic ApoE-LDLR pathway.
Ying Z; van Eenige R; Beerepoot R; Boon MR; Kloosterhuis NJ; van de Sluis B; Bartelt A; Rensen PCN; Kooijman S
Pharmacol Res; 2023 Jan; 187():106634. PubMed ID: 36574856
[TBL] [Abstract][Full Text] [Related]
5. Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development.
Zhou E; Hoeke G; Li Z; Eibergen AC; Schonk AW; Koehorst M; Boverhof R; Havinga R; Kuipers F; Coskun T; Boon MR; Groen AK; Rensen PCN; Berbée JFP; Wang Y
Cardiovasc Res; 2020 Aug; 116(10):1710-1720. PubMed ID: 31589318
[TBL] [Abstract][Full Text] [Related]
6. Role of Brown Fat in Lipoprotein Metabolism and Atherosclerosis.
Hoeke G; Kooijman S; Boon MR; Rensen PC; Berbée JF
Circ Res; 2016 Jan; 118(1):173-82. PubMed ID: 26837747
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
[TBL] [Abstract][Full Text] [Related]
8. Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice.
Liu C; Song Z; Li Z; Boon MR; Schönke M; Rensen PCN; Wang Y
Int J Obes (Lond); 2023 Mar; 47(3):236-243. PubMed ID: 36732416
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
[TBL] [Abstract][Full Text] [Related]
10. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
Wat E; Ng CF; Wong EC; Koon CM; Lau CP; Cheung DW; Fung KP; Lau CB; Leung PC
J Ethnopharmacol; 2016 Feb; 178():104-14. PubMed ID: 26666731
[TBL] [Abstract][Full Text] [Related]
11. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
[TBL] [Abstract][Full Text] [Related]
12. Brown adipose tissue activity controls triglyceride clearance.
Bartelt A; Bruns OT; Reimer R; Hohenberg H; Ittrich H; Peldschus K; Kaul MG; Tromsdorf UI; Weller H; Waurisch C; Eychmüller A; Gordts PL; Rinninger F; Bruegelmann K; Freund B; Nielsen P; Merkel M; Heeren J
Nat Med; 2011 Feb; 17(2):200-5. PubMed ID: 21258337
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
[TBL] [Abstract][Full Text] [Related]
14. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats.
Decara J; Rivera P; Arrabal S; Vargas A; Serrano A; Pavón FJ; Dieguez C; Nogueiras R; Rodríguez de Fonseca F; Suárez J
Acta Physiol (Oxf); 2018 Apr; 222(4):e13008. PubMed ID: 29193738
[TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin.
Salic K; Morrison MC; Verschuren L; Wielinga PY; Wu L; Kleemann R; Gjorstrup P; Kooistra T
Atherosclerosis; 2016 Jul; 250():158-65. PubMed ID: 27236706
[TBL] [Abstract][Full Text] [Related]
16. Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia.
Berbée JFP; Mol IM; Milne GL; Pollock E; Hoeke G; Lütjohann D; Monaco C; Rensen PCN; van der Ploeg LHT; Shchepinov MS
Atherosclerosis; 2017 Sep; 264():100-107. PubMed ID: 28655430
[TBL] [Abstract][Full Text] [Related]
17. Lipolysis Triggers a Systemic Insulin Response Essential for Efficient Energy Replenishment of Activated Brown Adipose Tissue in Mice.
Heine M; Fischer AW; Schlein C; Jung C; Straub LG; Gottschling K; Mangels N; Yuan Y; Nilsson SK; Liebscher G; Chen O; Schreiber R; Zechner R; Scheja L; Heeren J
Cell Metab; 2018 Oct; 28(4):644-655.e4. PubMed ID: 30033199
[TBL] [Abstract][Full Text] [Related]
18. USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.
Laurila PP; Soronen J; Kooijman S; Forsström S; Boon MR; Surakka I; Kaiharju E; Coomans CP; Van Den Berg SA; Autio A; Sarin AP; Kettunen J; Tikkanen E; Manninen T; Metso J; Silvennoinen R; Merikanto K; Ruuth M; Perttilä J; Mäkelä A; Isomi A; Tuomainen AM; Tikka A; Ramadan UA; Seppälä I; Lehtimäki T; Eriksson J; Havulinna A; Jula A; Karhunen PJ; Salomaa V; Perola M; Ehnholm C; Lee-Rueckert M; Van Eck M; Roivainen A; Taskinen MR; Peltonen L; Mervaala E; Jalanko A; Hohtola E; Olkkonen VM; Ripatti S; Kovanen PT; Rensen PC; Suomalainen A; Jauhiainen M
Sci Transl Med; 2016 Jan; 8(323):323ra13. PubMed ID: 26819196
[TBL] [Abstract][Full Text] [Related]
19. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
Geerling JJ; Boon MR; van der Zon GC; van den Berg SA; van den Hoek AM; Lombès M; Princen HM; Havekes LM; Rensen PC; Guigas B
Diabetes; 2014 Mar; 63(3):880-91. PubMed ID: 24270984
[TBL] [Abstract][Full Text] [Related]
20. Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans.
Ying Z; Tramper N; Zhou E; Boon MR; Rensen PCN; Kooijman S
Cardiovasc Res; 2023 May; 119(4):905-918. PubMed ID: 35944189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
